Venus Remedies Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent

Circuit Event and Unfilled Demand

The stock, trading in the EQ series, hit its maximum allowed daily gain of 5.0% within the 5% price band, closing firmly at Rs 1,219.10. This price represents a new 52-week and all-time high for Venus Remedies Ltd. The upper circuit mechanism effectively froze trading at this ceiling price, indicating that demand exceeded what the price band could accommodate. Buyers were willing to purchase shares at this elevated level, but sellers were absent, creating a scenario of unfilled demand. This dynamic is typical for stocks hitting their circuit limits, especially in micro-cap segments where liquidity is thinner and price bands are narrower.

Delivery and Volume Analysis

Volume on the circuit day was 39,669 shares, translating to a turnover of approximately Rs 4.84 crore. While total traded volume tends to be mechanically suppressed on circuit days due to the price lock, the delivery volume data offers a more insightful perspective on the quality of the move. On 26 May 2026, the delivery volume surged to 1.63 lakh shares, marking a remarkable 260.53% increase against the 5-day average delivery volume. This sharp rise in delivery volumes suggests that the shares traded were being taken into long-term holdings rather than merely exchanged intraday, signalling genuine buying conviction behind the upper circuit move. Venus Remedies Ltd's delivery data is the most revealing metric on this circuit day — does this surge in delivery volumes indicate sustained investor confidence or is it a short-lived phenomenon?

Moving Averages and Trend Context

Venus Remedies Ltd is trading above all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This alignment confirms a strong bullish trend preceding the circuit event. The stock opened at Rs 1,219.10 and remained locked at this price throughout the session, indicating a narrow intraday range with no retracement. The circuit thus amplified an already established upward momentum, reinforcing the breakout nature of the move. how sustainable is this trend confirmation given the micro-cap status and liquidity constraints?

Liquidity and Market Capitalisation Context

With a market capitalisation of Rs 1,629.57 crore, Venus Remedies Ltd is classified as a micro-cap stock. The liquidity profile is moderate, with the stock liquid enough to support a trade size of approximately Rs 0.26 crore based on 2% of the 5-day average traded value. While this level of liquidity is sufficient for retail and small institutional investors, it poses a cautionary note for larger participants due to the thin order book typical of micro-cap stocks. The upper circuit event in such a liquidity environment carries a dual message: it signals strong buying interest but also highlights the difficulty of entering or exiting sizeable positions without impacting the price. does the liquidity risk temper the enthusiasm around this upper circuit move?

Intraday Price Action

The stock opened at Rs 1,219.10 and traded exclusively at this price throughout the day, reflecting a zero intraday range. This price lock is characteristic of upper circuit hits, where the exchange restricts upward movement once the maximum gain is reached. The absence of any price fluctuation suggests that buyers were eager to accumulate shares at the ceiling price, while sellers were entirely absent. This scenario often results in a queue of unfulfilled buy orders, which may spill over into subsequent sessions once the circuit restrictions are lifted.

Brief Fundamental Context

Venus Remedies Ltd operates in the Pharmaceuticals & Biotechnology sector, an industry known for its growth potential and innovation-driven dynamics. The company’s recent performance has been robust, with the stock gaining 18.3% over the past four consecutive sessions, signalling sustained investor interest. While the upper circuit event is primarily a technical phenomenon, it coincides with a sector that has outperformed the broader market, as evidenced by the stock’s 4.73% outperformance relative to its sector on the day of the circuit hit.

Conclusion: Circuit, Delivery, and Liquidity Signals

The upper circuit hit at Rs 1,219.10 with a 5.0% gain for Venus Remedies Ltd was accompanied by a striking 260.53% rise in delivery volumes, underscoring genuine buying conviction rather than speculative frenzy. The stock’s position above all major moving averages further confirms a bullish trend that the circuit event amplified. However, the micro-cap status and moderate liquidity profile introduce a cautionary dimension — while the buying pressure is evident, the thin order book means that entering or exiting large positions could be challenging. The circuit locked in gains but also locked out buyers who arrived late, creating unfilled demand that may influence trading dynamics in the near term. after a 5.0% single-day gain at upper circuit, is Venus Remedies Ltd still worth considering or has the move already happened?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →